Back to Search
Start Over
Achondroplasia Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Ribomic Inc, Sanofi, Changchun GeneScience Pharma, QED
- Source :
- M2 Presswire. June 11, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-June 11, 2024-: Achondroplasia Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Ribomic Inc, Sanofi, Changchun GeneScience Pharma, QED (C)1994-2024 M2 [...]
- Subjects :
- Sanofi S.A. -- Forecasts and trends
BCG vaccines -- Forecasts and trends -- Reports
BCG -- Forecasts and trends -- Reports
Achondroplasia -- Reports -- Forecasts and trends
Drug approval -- Reports -- Forecasts and trends
Epidemiology -- Forecasts and trends -- Reports
Pharmaceutical industry -- Forecasts and trends
Somatropin -- Forecasts and trends -- Reports
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.797286938